findmyKOL
Clinical trialNCT01802034RecruitingObservational

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

SponsorThe Rogosin InstituteEnrollment2,000Diabetic NephropathyGlomerulonephritis, IGAKidney DiseasesKidney Failure, ChronicLupus Nephritis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the Rogosin Institute

    New York, New York, United States

    Alan S Perlman, MDCholi Hartono, MDDaniel M Levine, PhDDavid Serur, MDJames M Chevalier, MDJohn CL Wang, MDJun Lee, MDLiu M Frank, MDManikkam Suthanthiran, MDMeredith J Aull, PharmDNathaniel Berman, MDNelson Chen, CRCSurya V Seshan, MDThomas S Parker, PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2013
Primary completion
31 Aug 2028
Completion
31 Aug 2028
Last update posted
4 Apr 2025
Registered enrollment
2,000
Registry id
NCT01802034

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.